Transdermal technology
Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of Targeted Osteoarthritis Therapy.
BioChemics & Beth Israel Deaconess Medical Center Announce Wound Healing Research Collaboration. April 8, 2008
Nanobac Pharmaceuticals, Inc. Announces Collaboration Agreement With BioChemics for Transdermal Therapeutic Formulation.
Tuesday March 25, 9:46 am ET
John Masiz founder of BioChemics is interviewed by Sky Radio from Valley Village, California. Radio interview includes topics about VALE and the future of BioChemics. Tuesday, March 4, 2008
